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Traditional medicines, in particular herbal products, have been used abundantly over the years in curing
several diseases. Pharmacological interactions of herbal products with modern drugs, however, remain to
some extent unknown. Herein, we examined whether co-administration of Faizol Ubat Batuk (FUB), a
mixture of aqueous extract of different plants, modifies the metabolism of aminopyrine, a conventional
analgesic drug, in rat liver. We used rat hepatocytes outfitted by collagenase perfusion technique.
Determination of aminopyrine n-demethylase activity was performed using the Nash colorimetric method,
by measuring the amount of formaldehyde produced. Compared to control treatment, FUB significantly
increased the hepatic metabolism of aminopyrine in healthy adult male rats. In contrast, the hepatic
metabolism of aminopyrine in adult female rats was decreased. Besides, a biphasic effect in n-demethylase
activity was observed in young male rats treated with FUB. In a subsequent experiment, FUB did not change
the metabolism of aminopyrine in streptozotocin (STZ)-diabetic adult male rats. In conclusion, administra-
tion of FUB could affect phase I aminopyrine metabolism in rat heptocytes. In addition, the effects of FUB
on hepatic n-demethylase activity were gender and disease dependent.
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T
raditional remedies have been used for thousands
of years to maintain health. Nowadays they are
still used either alone or in conjunction with
modern drugs. The majority of populations take tradi-
tional medicines following experiences adopted by elders
and ancestors. Most of the people believe that natural
products are good and wholesome, whereas synthetic
products are bad and poisonous. Hence, WHO reported
that traditional medicines should be integrated into
primary care in order to offer the best means of achieving
the goal of health-care for the entire population (1, 2).
However, the majority of traditional medicines, either
obtained from one plant or mixture of plants, need to be
investigated scientifically in order to understand and to
appreciate the experience obtained from their traditional
uses. In general, herbal preparations, consumed by the
public, contain a mixture of plant extracts. Hence, the
active ingredients are unclear. Accordingly, the therapeu-
tic outcomes and the adverse effects are achieved from
the summation of all those ingredients present inside the
herbal product. So, in view of the progress of modern
medicine, not only the synthetic drugs but also the herbal
drugs have to fulfill the international requirements on
safety and efficacy (3). Consequently, analysis of the
herbal products is of more immediate relevance with
respect to the health benefit or risk to consumers.
Herbdrug interactions are able to induce an enhance-
ment or decrease in efficacy of co-administered drugs.
Pharmacokinetic interactions have been studied, and in
vivo and in vitro experiments indicated that the altered
drug concentrations by the co-administered herbs may be
attributable to the induction or inhibition of hepatic
drug-metabolizing enzymes, in particular cytochrome
P450 (4). Aminopyrine, a model drug, is an analgesic
drug and is currently rarely used due to its dangerous side
effects. Aminopyrine n-demethylase enzyme is classified
as n-dealkylation reaction, which belongs to one of the
oxidation processes in the phase I hepatic drug metabo-
lism reaction (5). The present study aims to investigate
the acute (1-day treatment) effect of Faizol Ubat Batuk
(FUB), a mixture of 11 different extracts of certain Malay
plants, and it is traditionally used to treat common cold
diseases (Fig. 1) on the hepatic aminopyrine metabolism
in healthy and diabetic rat hepatocytes.
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Chemicals
All chemicals used were of analytical grade purity.
Collagenase (type IV), streptozotocin (STZ), and amino-
pyrine were obtained from Sigma Chemical Co. (St.
Louis, MO, USA). The FUB was purchased from Faizol
Industri, sdn. Bhd. Kuala Kangsar, Malaysia. The
compositions of FUB were as follows: Duan Perya 5%;
Daun Asam Jawa 10%; Buah Kembang Semangkuk 10%;
Buah Bemban 5%; Lobak Ubi 20%; Agar-agar 14%;
Rumput Laut 5%; Menthol 1%; Umbut Pisang 5%;
Getah Angur 10% and Madu 15%.
Experimental animals and induction of diabetes
Healthy adult male and female (1820 weeks old; 210290
g; n6 each group) and young male (810 weeks old; 85
103 g; n6) rats of the Sprague Dawley (SD) strain were
used. The rats were obtained from the animal house,
Pharmacy Discipline, Universiti Sains Malaysia (USM),
Pinang, Malaysia. The animals were housed in macrolon
cages in laminar flow cabinet, 24 animals per cage, under
standard environmental condition, and provided with
food (Gold Coin) and water ad libitum. Animal care and
use were conducted in accordance with the Animal Ethics
Committee of USM, Malaysia, 1998.
The STZ-induced diabetes has been demonstrated to
affect drug metabolism. Herein, hyperglycemia was
induced by intravenous injection of STZ (60 mg/kg) in
distilled water, via rat-tail. Increased blood glucose level
was confirmed on the third day after administration of
STZ. Animals (n6) showed high blood glucose levels
(higher than 300 mg/dl at fasting state), measured by
using Extac Tech glucometer (Medisense, USA) (6).
Preparation of hepatocytes and liver enzyme assay
The protocol used for isolation of hepatocytes was
performed by using the modified collagenase perfusion
technique as previously described (79). Rats received
orally equal volume of serial dilutions of FUB in water,
ranging from one tenth to one tenth million on day zero.
The STZ-diabetic rats received FUB on day 4 post-STZ
injection. Control rats were treated the same but had the
FUB replaced with water. Twenty four hours after the
administration of FUB, rats were anaesthetised with
ether and the liver perfused in situ through the hepatic
portal vein with calcium-free Hank’s Balanced Salt
Solution (HBSS) for 15 min. Hereafter, the collagenase
buffer (HBSS supplemented with 4 mM calcium chloride
and collagenase 0.5 mg/ml) was perfused until the liver
appeared to have broken up. The liver was removed from
the animal, and the cells were dispersed in calcium-free
HBSS using steel forceps. The cell suspension was filtered
through gauze and centrifuged at 200g for 5 min (in a
Hettich Universal Centrifuge) to clean the parenchymal
cells of debris. The supernatant was drained out, and the
cells were resuspended in incubation medium (HBSS
supplemented with 1 g/L glucose, 100 mg/L MgSo4, 100
mg/L MgCl2 and 185 mg/L CaCl2; pH 7.4). The cells were
then counted using a haemocytometer and assayed for
viability using trypan blue exclusion method. The average
yield was 510
7 cells/g liver, and viability was routinely
greater than 90% for all preparations.
Then, the cells were plated out on 90-mm petri dishes
(Medical Product, Malaysia) at a density of 610
3 cells/
10 ml incubation medium as previously described (10).
Aminopyrine dissolved in distilled water was added
directly to the petri dish at a final concentration 250
mmol/L. The experiment was done in quadruplicates.
Petri dishes were then shaken using a table top shaker
(Belly Dancer, Stoval, USA) and incubated in CO2
incubator (Queue Systems Inc. Model 2710) for 18 min
at 378C (7, 8, 10). Aminopyrine n-demethylase activity
was measured at 415 nm to determine the quantity of
formaldehyde formed according to the colorimetric
method of Nash (11).
Statistical analysis
Aminopyrine n-demethylase activity is expressed in nmol/
min/million cells. Data are expressed as mean enzyme
activity9SEM. The statistical significance of the differ-
ences was assessed using the Student’s t-test. In all the
cases, a probability value PB0.05 was considered statis-
tically significant. Analyses were performed by using
GraphPad Prism (GraphPad Software Inc., version 3.0,
San Diego, USA).
Fig. 1. The herbal product Faizol Ubat Batuk (FUB).
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In contrast to allopathic remedy where the content and
dose of active ingredient in any dosage form is well
quantitated, the pharmacological actions using herbal
medical preparations are derived from the effects of the
total ingredients. In the present study, findings indicated
that co-administration of FUB, a multiple herbal ingre-
dient concoction traditionally used to treat common cold
diseases, changed the hepatic phase I metabolism of
aminopyrine in rat liver.
Aminopyrine undergoes phase I n-demethylation in the
liver in the presence of cytochrome P-450 n-demethylase.
Studies in rat hepatocytes showed that the hepatic
n-demethylase enzyme activity can be, indirectly, deter-
mined throughout the aminopyrine metabolism by mea-
suring the quantity of formaldehyde formed (12). The
present study showed that the metabolism of aminopyr-
ine is changed in the presence of FUB. Compared to
control-treated rats, FUB significantly increased the in
vitro hepatic metabolism of aminopyrine in adult male
rats by 30% (P B 0.05, Fig. 2), indicating the induction
of hepatic enzyme activities following treatment with
this traditional medicine, FUB. However, this increase in
n-demethylase activity was not dose dependent because
increased FUB concentrations did not increase further
the hepatic phase I metabolism of aminopyrine (Fig. 2).
In addition, the effect of FUB on n-demethylase enzyme
activity was gender dependent. In adult female rats,
co-administration of FUB did significantly reduce
(21% decrease, P B 0.05, Fig. 2) the aminopyrine
n-demethylase activity. Therefore, these results show
that FUB alters aminopyrine metabolism, and that this
effect is gender dependent.
In young male rats, our data showed that FUB has
biphasic effects, increased the enzyme activity at lower
concentrations, while at higher concentrations FUB
reduced the metabolism of aminopyrine in rat hepato-
cytes (Fig. 2). As can be seen from figure 2, young male
rats responded similarly to adult male rats to FUB
mainly at lowest concentrations at above 1:100,000
dilutions, indicating that the influence of FUB on
aminopyrine metabolism is not affected by age. None-
theless, as in normal and young male rats, the observed
effects varied depending on the concentrations used age
factor has a significant effect on FUB influence, mostly at
highest concentration at beneath 1:10,000 dilutions, on
aminopyrine metabolism. In contrast, difference in rat
gender has a significant effect on FUB influence on
hepatic phase I n-demethylase activity at all tested FUB
dilutions (Fig. 2).
In a different study, our findings showed that 1-day
oral administration of FUB showed little effect on the
metabolism of aminopyrine in adult male STZ-diabetic
rats compared to STZ-diabetic control rats (Fig. 2). The
total amount of formaldehyde formed (in absolute value)
is shown in table 1. Therefore, in addition to being gender
dependent, it seems that the influence of FUB on
aminopyrine n-demethylase activity is also disease de-
pendent since the n-demethylase activity being markedly
enhanced in healthy rats while less affected in STZ-
diabetic rats.
The present study displayed that FUB differently
affects the aminopyrine n-demethylase enzyme activity.
However, it is not known which of the plant extract used
in the concoction of FUB is responsible for those
observed effects. Moreover, the mechanisms by which
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Fig. 2. Doseresponse effect of FUB on aminopyrine metabolism in hepatocytes obtained from healthy adult male rats (m),
healthy adult female rats (j), healthy young male rats ('), STZ-diabetic male rats ("). Each dose done in quadruplicate, n6
each. Control: hepatocytes obtained from matched animal group treated with distilled water. Values are expressed as percentage
of the relevant control9SEM. *PB0.05 compared to their respective control.
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known at present. Since in vitro incubation of FUB with
rat liver hepatocytes did not change the metabolism of
aminopyrine (data not shown), a direct affect of FUB
on the n-demethylase enzyme activity is probably not
at play. Hence, it seems likely that FUB changes the
cytochrome P450 activity by indirect mechanisms. More-
over, it cannot be totally excluded that the in vivo effects
of FUB are rather related to its actions on other
physiological systems. Several studies have demonstrated
that cytochrome P450 activity is changed after phosphor-
ylation (13, 14). Therefore, it appears likely that while
FUB, dose independently, changed the cytochrome P450
activity, FUB phosphorylated cytochrome P450 in male
rats and de-phosphorylated cytochrome P450 in female
rats. Our present data are in agreement with other
studies, demonstrating that a change in aminopyrine
metabolism is sex dependent (1517).
Age differences in pharmacokinetics and hepatic drug
metabolism had been well documented in rodent models
(18, 19). Similarly, de Wildt and his colleagues extra-
polate those findings in human studies (20). In the
present study, our findings are not completely in line
with the studies (18, 19), since the metabolism of
aminopyrine in adult male rats is not significantly
different from that in young male rats, mainly at FUB
lower concentrations. One likely explanation for this
discrepancy may be that the other studies (18, 19) used
a direct in vitro incubation of aminopyrine with herbal
extract, whereas we treated our rats systemically with
FUB. Various other studies have indicated that diabetes
produce substantial changes in intracellular metabolism
in most tissues including liver and play a significant
role in drug metabolism (16, 21). In agreement with
the literature, our findings showed that the hepatic
metabolism of aminopyrine is slightly affected in diabetic
rats while significantly enhanced in non diabetic (healthy)
rats (22, 23). These findings provide further support for
contributing this biological factor in drug metabolism.
Conclusion
The present study indicates that co-administration of
FUB preparations was able to manipulate the hepatic
metabolism of aminopyrine in rat liver. A possibility
exists that interactions occur with other drugs that
undergo hepatic phase-I n-demethylation process, such
as imipramine, chlorpromazine, morphine, and phe-
nothiazine, and uncertainly reduces their bioavailability.
Moreover, it is apparent that gender and induced diabetes
modifies the effect of FUB. A likely, but only at higher
concentrations, the influence of FUB on aminopyrine
metabolism was age dependent. Whether the results
obtained are similarly reproduced in humans still needs
further investigation.
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